Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Inhibitor"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"330 - Economics"
Search alternatives
:
inhibitor »
inhibitors
,
inhibition
Showing
1
-
20
of
59
Search:
'"Inhibitor"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic review report: Dolutegravir/Rilpivirine (Juluca) : (ViiV healthcare ULC)
Published 2018
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
2
Pharmacoeconomic review report: Dolutegravir/Rilpivirine (Juluca) : (ViiV healthcare ULC)
Published 2018
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
5
Pharmacoeconomic review report: Nitisinone (Nitisinone tablets) (Cycle Pharmaceuticals Ltd.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in comb...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme
Inhibitors
/ therapeutic use...
”
Read Now
6
Pharmacoeconomic review report: Nitisinone (Nitisinone tablets) (Cycle Pharmaceuticals Ltd.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in comb...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme
Inhibitors
/ therapeutic use...
”
Read Now
7
Pharmacoeconomic review report: Upadacitinib (Rinvoq) (AbbVie) : indication: for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an ina...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Janus Kinase
Inhibitors
/ therapeutic use...
”
Read Now
8
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Platelet Aggregation
Inhibitors
/ adverse effects...
”
Read Now
9
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration
by
Wells, George A.
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Platelet Aggregation
Inhibitors
/ adverse effects...
”
Read Now
10
Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : recommendations
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Platelet Aggregation
Inhibitors
/ adverse effects...
”
Read Now
11
Pharmacoeconomic review report: Nitisinone (MDK-Nitisinone) (MendeliKABS inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme
Inhibitors
/ therapeutic use...
”
Read Now
12
Pharmacoeconomic review report: Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation)
Published 2018
CADTH
Subjects:
“
...Protease
Inhibitors
/ economics...
”
Read Now
13
Pharmacoeconomic review report: Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation)
Published 2018
CADTH
Subjects:
“
...Protease
Inhibitors
/ economics...
”
Read Now
14
Pharmacoeconomic review report: Empagliflozin (Jardiance)
Published 2015
CADTH
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
15
Pharmacoeconomic review report: Empagliflozin (Jardiance)
Published 2015
CADTH
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
16
Pharmacoeconomic review report: Dolutegravir/Lamivudine (Dovato) (ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunodeficiency virus type1 (...
Published 2019
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ economics...
”
Read Now
17
Pharmacoeconomic review report: Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patients two y...
Published 2019
CADTH
Subjects:
“
...Phosphodiesterase 4
Inhibitors
/ therapeutic use...
”
Read Now
18
Pharmacoeconomic review report: Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patients two y...
Published 2019
CADTH
Subjects:
“
...Phosphodiesterase 4
Inhibitors
/ therapeutic use...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Subjects:
“
...Phosphodiesterase 4
Inhibitors
/ therapeutic use...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Subjects:
“
...Phosphodiesterase 4
Inhibitors
/ therapeutic use...
”
1
2
3
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
31
000 - Computer science, information & general works
10
700 - The arts; fine & decorative arts
10
580 - Plants (Botany)
6
140 - Specific philosophical schools
5
more ...
333 - Economics of land & energy
5
363 - Other social problems & services
4
304 - Factors affecting social behavior
2
380 - Commerce, communications & transportation
2
600 - Technology
2
800 - Literature & rhetoric
2
540 - Chemistry & allied sciences
1
551 - Geology, hydrology & meteorology
1
576 - Genetics & evolution
1
581 - Specific topics in natural history
1
620 - Engineering & allied operations
1
630 - Agriculture & related technologies
1
658 - General management
1
see all ...
less ...
Language
English
59
Collection
National Center for Biotechnology Information
46
Directory of Open Access Books
13
Author
Canadian Agency for Drugs and Technologies in Health
38
CADTH Canadian Drug Expert Committee
16
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
3
Campbell, Kaitryn
2
Es-Safi, Nour Eddine
2
Young, Calvin
2
more ...
Aaserud, Morten
1
Alesina, Pier Francesco
1
Appenroth, Klaus-Jürgen
1
Argáez, Charlene
1
Barata, Carlos
1
Bhattarai, Rewati
1
Calabi-Floody, Marcela
1
Choi, Young Hae
1
Dai, Yuntao
1
Faria, Melissa
1
Farooque, Aitazaz A.
1
Jang, Young Pyo
1
Johnson, Stuart
1
Lamponi, Stefania
1
Lipman, Jeffrey
1
Martín, Carlos
1
Medas, Fabio
1
Movik, Espen
1
Nasjonalt kunnskapssenter for helsetjenesten
1
Neilson, Aileen Rae
1
Oláh, Viktor
1
Raldúa, Demetrio
1
Rumpel, Cornelia
1
Salomé-Abarca, Luis Francisco
1
Shamshiri, Redmond R.
1
Sree, K. Sowjanya
1
Sultan, Muhammad
1
Thompson, Wade
1
Wells, George A.
1
Xie, Jianhua
1
Yu, Hansong
1
Zhang, Yanjun
1
Zhou, Yuguang
1
de la Luz Mora, Maria
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%22Inhibitor%22&type=Subject
Send by Email
×
Loading...